paliperidone palmitate 156 MG/ML [Erzofri]
RxNorm concept 2699344, branded drug component (sbdc).
- RxCUI
- 2699344
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2699344 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 2.25 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Erzofri] (SBD, constitutes)
- 0.75 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Erzofri] (SBD, constitutes)
- 1 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Erzofri] (SBD, constitutes)
- 1.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Erzofri] (SBD, constitutes)
- 0.25 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Erzofri] (SBD, constitutes)
- 0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Erzofri] (SBD, constitutes)
- Erzofri (BN, has ingredient)
- paliperidone palmitate 156 MG/ML (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2699344 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2699344 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2699344. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.